188 related articles for article (PubMed ID: 22293863)
21. Novel human neutrophil agonistic properties of arsenic trioxide: involvement of p38 mitogen-activated protein kinase and/or c-jun NH2-terminal MAPK but not extracellular signal-regulated kinases-1/2.
Binet F; Girard D
J Leukoc Biol; 2008 Dec; 84(6):1613-22. PubMed ID: 18728151
[TBL] [Abstract][Full Text] [Related]
22. The effects of MAPK inhibitors on antimycin A-treated calf pulmonary arterial endothelial cells in relation to cell death, reactive oxygen species and glutathione.
Han YH; You BR; Moon HJ; Kim SZ; Kim SH; Park WH
Mol Med Rep; 2010; 3(1):161-6. PubMed ID: 21472216
[TBL] [Abstract][Full Text] [Related]
23. Activation of the p38 MAPK/Akt/ERK1/2 signal pathways is required for the protein stabilization of CDC6 and cyclin D1 in low-dose arsenite-induced cell proliferation.
Liu Y; Hock JM; Sullivan C; Fang G; Cox AJ; Davis KT; Davis BH; Li X
J Cell Biochem; 2010 Dec; 111(6):1546-55. PubMed ID: 20862710
[TBL] [Abstract][Full Text] [Related]
24. Proteasome inhibition by MG132 induces growth inhibition and death of human pulmonary fibroblast cells in a caspase-independent manner.
You BR; Park WH
Oncol Rep; 2011 Jun; 25(6):1705-12. PubMed ID: 21399877
[TBL] [Abstract][Full Text] [Related]
25. Enhancement of arsenic trioxide-induced apoptosis in HeLa cells by diethyldithiocarbamate or buthionine sulfoximine.
Han YH; Kim SZ; Kim SH; Park WH
Int J Oncol; 2008 Jul; 33(1):205-13. PubMed ID: 18575767
[TBL] [Abstract][Full Text] [Related]
26. ASK1 is activated by arsenic trioxide in leukemic cells through accumulation of reactive oxygen species and may play a negative role in induction of apoptosis.
Yan W; Arai A; Aoki M; Ichijo H; Miura O
Biochem Biophys Res Commun; 2007 Apr; 355(4):1038-44. PubMed ID: 17331470
[TBL] [Abstract][Full Text] [Related]
27. Arsenic trioxide induces human pulmonary fibroblast cell death via the regulation of Bcl-2 family and caspase-8.
Park WH; Kim SH
Mol Biol Rep; 2012 Apr; 39(4):4311-8. PubMed ID: 21779797
[TBL] [Abstract][Full Text] [Related]
28. The synergistic antitumor activity of arsenic trioxide and vitamin K2 in HL-60 cells involves increased ROS generation and regulation of the ROS-dependent MAPK signaling pathway.
Qu H; Tong D; Zhang Y; Kang K; Zhang Y; Chen L; Ren L
Pharmazie; 2013 Oct; 68(10):839-45. PubMed ID: 24273890
[TBL] [Abstract][Full Text] [Related]
29. MAPK inhibitors, particularly the JNK inhibitor, increase cell death effects in H2O2-treated lung cancer cells via increased superoxide anion and glutathione depletion.
Park WH
Oncol Rep; 2018 Feb; 39(2):860-870. PubMed ID: 29207156
[TBL] [Abstract][Full Text] [Related]
30. Gallic acid-induced lung cancer cell death is related to glutathione depletion as well as reactive oxygen species increase.
You BR; Park WH
Toxicol In Vitro; 2010 Aug; 24(5):1356-62. PubMed ID: 20417267
[TBL] [Abstract][Full Text] [Related]
31. MG132, a proteasome inhibitor-induced calf pulmonary arterial endothelial cell growth and death, are changed by MAPK inhibitors.
You BR; Park WH
Drug Chem Toxicol; 2011 Jan; 34(1):45-52. PubMed ID: 20954830
[TBL] [Abstract][Full Text] [Related]
32. MG132, a proteasome inhibitor, induces human pulmonary fibroblast cell death via increasing ROS levels and GSH depletion.
Park WH; Kim SH
Oncol Rep; 2012 Apr; 27(4):1284-91. PubMed ID: 22266922
[TBL] [Abstract][Full Text] [Related]
33. The effects of MAPK inhibitors on a proteasome inhibitor, MG132-induced HeLa cell death in relation to reactive oxygen species and glutathione.
Han YH; Park WH
Toxicol Lett; 2010 Feb; 192(2):134-40. PubMed ID: 19854251
[TBL] [Abstract][Full Text] [Related]
34. Enhanced cell death effects of MAP kinase inhibitors in propyl gallate-treated lung cancer cells are related to increased ROS levels and GSH depletion.
Park WH
Toxicol In Vitro; 2021 Aug; 74():105176. PubMed ID: 33865947
[TBL] [Abstract][Full Text] [Related]
35. Synergistic induction of apoptosis by sulindac and arsenic trioxide in human lung cancer A549 cells via reactive oxygen species-dependent down-regulation of survivin.
Jin HO; Yoon SI; Seo SK; Lee HC; Woo SH; Yoo DH; Lee SJ; Choe TB; An S; Kwon TJ; Kim JI; Park MJ; Hong SI; Park IC; Rhee CH
Biochem Pharmacol; 2006 Nov; 72(10):1228-36. PubMed ID: 16950207
[TBL] [Abstract][Full Text] [Related]
36. Enhancement of propyl gallate-induced calf pulmonary arterial endothelial cell death by MEK and JNK inhibitors.
Han YH; Kim SZ; Kim SH; Park WH
Mol Med Rep; 2009; 2(5):825-30. PubMed ID: 21475908
[TBL] [Abstract][Full Text] [Related]
37. Arsenic trioxide-induced cytotoxicity in small cell lung cancer via altered redox homeostasis and mitochondrial integrity.
Zheng CY; Lam SK; Li YY; Ho JC
Int J Oncol; 2015 Mar; 46(3):1067-78. PubMed ID: 25572414
[TBL] [Abstract][Full Text] [Related]
38. Helicobacter pylori and mitogen-activated protein kinases regulate the cell cycle, proliferation and apoptosis in gastric epithelial cells.
Ding SZ; Smith MF; Goldberg JB
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e67-78. PubMed ID: 18702686
[TBL] [Abstract][Full Text] [Related]
39. The MEK inhibitor PD98059 attenuates growth inhibition and death in gallic acid-treated Calu-6 lung cancer cells by preventing glutathione depletion.
Han YH; Moon HJ; You BR; Yang YM; Kim SZ; Kim SH; Park WH
Mol Med Rep; 2010; 3(3):519-25. PubMed ID: 21472273
[TBL] [Abstract][Full Text] [Related]
40. Curcumin stimulates reactive oxygen species production and potentiates apoptosis induction by the antitumor drugs arsenic trioxide and lonidamine in human myeloid leukemia cell lines.
Sánchez Y; Simón GP; Calviño E; de Blas E; Aller P
J Pharmacol Exp Ther; 2010 Oct; 335(1):114-23. PubMed ID: 20605902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]